Treatment Schedules for 5-Ht2a Blocking in Progressive Multifocal Leukoencephalopathy Using Risperidone or Ziprasidone

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1705682
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Progressive Multifocal Leukoencephalopathy

Journal of Multiple Sclerosis
2013English

Progressive Multifocal Leukoencephalopathy

Neurology
Neurology
2002English

Treatment of Progressive Multifocal Leukoencephalopathy With Interleukin 7

JAMA Neurology
Neurology
2014English

Progressive Multifocal Leukoencephalopathy: Current Insights

Degenerative Neurological and Neuromuscular Disease
2019English

Treatment-Related Progressive Multifocal Leukoencephalopathy: Current Understanding and Future Steps

Therapeutic Advances in Drug Safety
Pharmacology
2012English

Rituximab-Associated Inflammatory Progressive Multifocal Leukoencephalopathy

Case Reports in Infectious Diseases
2016English

Neuropharmacokinetic Heterogeneity of Mefloquine in the Treatment of Progressive Multifocal Leukoencephalopathy

Internal Medicine
Internal MedicineMedicine
2012English

Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy

Frontiers in Neurology
Neurology
2020English

Progressive Multifocal Leukoencephalopathy in the Absence of Immunosuppression

Journal of NeuroVirology
VirologyNeurologyCellularMolecular Neuroscience
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy